According to market analysis, the worldwide market for adult vaccines is projected to reach a value of US$ 16,790.11 million in 2022 and is anticipated to demonstrate a compound annual growth rate (CAGR) of 7.1% from 2023 to 2030.
Vaccines are used to develop immunity to a specific disease and it is a biological preparation. Immunization is a continues process that starts from childhood. Immunity power of an adult can wear off with years pass by and can be at risk of new infectious diseases. Changes are happening in the recommendations of vaccines over the years. Also, some vaccines are newly introduced, which were not available in childhood. Due to all these facts, it is very important to ensure adult immunization of a person is up-to-date, especially regarding pregnant women. Immunizations needed for an adult is based on many factors such as medical conditions, health, lifestyle, age, previous immunizations, and travel.
The prevention of diseases in both adults and children is facilitated through vaccination and immunization. Vaccines are comprised of biological suspensions containing agents that imitate disease-causing microorganisms. These agents are typically created using inactivated microbes, toxins, or surface proteins. Once administered, the active agents within the vaccine stimulate the immune system to identify the disease-causing agent as a foreign substance and generate antibodies to fight against it. While vaccines are a preferred and strongly recommended method of disease prevention, they may cause mild side effects such as fever, headaches, and body aches.
To Get More Business Strategies Request for Sample Copy @ https://www.coherentmarketinsights.com/insight/request-sample/1091
Note – Updated Version 2023 is available
Our Sample Report May Includes:
‣ 2030 Updated Report Introduction, Overview, and In-depth industry analysis.
‣ 100+ Pages Research Report (Inclusion of Updated Research).
‣ Provide Chapter-wise guidance on Requests.
‣ 2023 Updated Regional Analysis with Graphical Representation of Size, Share & Trends
‣ Includes Updated List of tables & figures.
‣ Updated Report Includes Top Market Players with their Business Strategy, Sales Volume, and Revenue Analysis.
The market expansion is anticipated to be fueled by the numerous nations that are running national immunisation programmes to give vaccination and raise awareness about the benefits of vaccination to prevent fatal diseases.
The global market for adult vaccines is expected to be driven by various countries that are implementing national immunization programs during the forecast period. For example, on February 17, 2022, the Centers for Disease Control and Prevention (CDC) released updated influenza vaccine schedules for adults in 2022. Additionally, on January 12, 2022, the CDC’s Advisory Committee on Immunization Practices (ACIP) reviewed presentations on seasonal influenza vaccines by H. Keipp Talbot, MD, MPH, and influenza vaccines for older adults by Lisa Grohskopf of the Vaccine Policy Unit.
Additionally, in June 2022, the Australian Government Department of Health reported that the National Immunization Program (NIP) provides funding for influenza vaccines for individuals who are at the highest risk of contracting the influenza virus. As public health measures related to the global COVID-19 pandemic are relaxed domestically and internationally, it is expected that there will be a resurgence of influenza in 2022, leaving the Australian community potentially more vulnerable to the virus during the winter months. Therefore, the Australian government has taken the initiative to vaccinate the population against influenza.
The global market for adult vaccines is anticipated to develop as a result of the rising number of government initiatives to stop specific outbreaks and diseases.
The global adult vaccines market is expected to experience growth driven by an increasing number of government initiatives aimed at preventing certain diseases and epidemics. For instance, the National Health Mission has committed to eliminating measles and controlling rubella in India. As part of this effort, the Measles Rubella (MR) vaccine was introduced in the country through a phased campaign in 2017. The MR campaign targets around 4.1 million children between the ages of 9 months to 15 years, covering approximately one-third of the total population of India, and is followed by two routine immunization doses at 9-12 months and 16-24 months. The rubella component is now included in routine immunization through the MR vaccine.
In addition, the Pneumococcal Conjugate Vaccine (PCV) was launched in India in May 2017 to reduce infant mortality and morbidity resulting from pneumococcal pneumonia. PCV has since been introduced in several Indian states, including Bihar, Himachal Pradesh, Madhya Pradesh, 19 districts of Uttar Pradesh, and 18 districts of Rajasthan. To provide technical training for the repair and maintenance of cold chain equipment, the National Cold Chain Training Centre (NCCTE) in Pune and the National Cold Chain & Vaccine Management Resource Centre (NCCVMRC) – National Institute of Health and Family Welfare (NIHFW) in New Delhi were established in 2019.
Key Players
GlaxoSmithKline Plc, Merck & Co., Sanofi Pasteur, Pfizer Inc., CSL Limited, Johnson & Johnson, Serum Institute of India, Medimmune, and AstraZeneca Plc are major players operating in the global adult vaccines market.
Direct Buy This Premium Research Report: https://www.coherentmarketinsights.com/insight/buy-now/1091
Adult Vaccines Market Report Coverage
| The market size value in 2023 |
Global Adult Vaccines Market – Impact of Coronavirus (COVID-19) Pandemic
The outbreak of the COVID-19 virus began in December 2019 and has since spread to more than 100 countries worldwide. On January 30, 2020, the World Health Organization (WHO) declared COVID-19 a public health emergency.
The COVID-19 pandemic can impact the economy in three primary ways: firstly, by directly affecting the production and demand of pharmaceutical drugs; secondly, by creating disruptions in the distribution channels; and thirdly, through its financial impact on firms and financial markets. As a result of nationwide lockdowns, various countries, including China, India, Saudi Arabia, the U.A.E., Egypt, and others, are encountering challenges with transporting drugs from one location to another.
The global adult vaccines market experienced a favorable effect from the COVID-19 pandemic due to the increased focus on research and development to create a vaccine to prevent coronavirus. An example of this is the Pfizer-BioNTech COVID-19 vaccine, which was globally available under Emergency Use Authorization (EUA) for individuals 16 years of age and older as of December 11, 2020, and was the first COVID-19 vaccine approved by the U.S. Food and Drug Administration.
Global Adult Vaccines Market: Key Developments
The use of influenza vaccines during the 2021-2022 influenza season was updated in September 2021 by the Centers for Disease Control and Prevention (CDC)’s Advisory Committee on Immunization Practices. Additionally, the U.S. Food and Drug Administration approved Flucelvax Quadrivalent, an inactivated influenza vaccine based on cell culture, for use in the United States in October 2021.
Global Adult Vaccines Market: Restraint
One of the significant challenges that hinder the growth of the global adult vaccines market is the large population that remains unvaccinated for certain diseases like Tetanus, Diphtheria, and Pertussis. For instance, as per the 2021 National Health Interview Survey conducted by the Centers for Disease Control & Prevention (CDC), 4 out of 5 people did not report getting vaccinated for Tdap in the U.S. In addition, the COVID-19 pandemic had a negative impact on adult vaccination coverage in 2020 since few adults visited healthcare professionals where vaccinations are typically administered.
Reasons To Buy The Adult Vaccines Market Report:
➼ In-depth analysis of the market on the global and regional levels.
➼ Major changes in market dynamics and competitive landscape.
➼ Segmentation on the basis of type, application, geography and others.
➼ Historical and future market research in terms of size, share growth, volume, and sales.
➼ Major changes and assessment in market dynamics and developments.
➼ Emerging key segments and regions
➼ Key business strategies by major market players and their key methods.
Request for Enquiry or Customization @ https://www.coherentmarketinsights.com/insight/request-customization/1091
Table of Contents with Major Points:
Executive Summary
- Introduction
- Key Findings
- Recommendations
- Definitions and Assumptions
Executive Summary
Market Overview
- Definition of Adult Vaccines Market
- Market Dynamics
- Drivers
- Restraints
- Opportunities
- Trends and Developments
Key Insights
- Key Emerging Trends
- Key Developments Mergers and Acquisition
- New Product Launches and Collaboration
- Partnership and Joint Venture
- Latest Technological Advancements
- Insights on Regulatory Scenario
- Porters Five Forces Analysis
Qualitative Insights Impact of COVID-19 on Global Adult Vaccines Market
- Supply Chain Challenges
- Steps taken by Government/Companies to overcome this impact
- Potential opportunities due to COVID-19 outbreak
Conclusion
Appendix
- Data Sources
- Abbreviations
- Disclaimer
TOC Continued…!
Explore More Report:
India immune oncology drugs market
Halal nutraceuticals and vaccines market
Colombia wound care biologics market
Hpapis and cytotoxic drugs manufacturing market
Subcutaneous drug delivery market
About Us:
Coherent Market Insights is a global market intelligence and consulting organization that provides syndicated research reports, customized research reports, and consulting services. We are known for our actionable insights and authentic reports in various domains including aerospace and defense, agriculture, food and beverages, automotive, chemicals and materials, and virtually all domains and an exhaustive list of sub-domains under the sun. We create value for clients through our highly reliable and accurate reports. We are also committed in playing a leading role in offering insights in various sectors post-COVID-19 and continue to deliver measurable, sustainable results for our clients.
Contact:
Mr Shah
Coherent Market Insights
533 Airport Boulevard, Suite 400, Burlingame,
CA 94010, United States.
Email: sales@coherentmarketinsights.com
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027
Japan: +050-5539-1737
India: +91-848-285-0837